Intracerebroventricular injection of erythropoietin enhances sleep in the rat

Brain Research Bulletin

Volumn 61, Issue 5, 2003, Pages 541-546

  García García, Fabio ^a   Krueger, James M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Brain; Cytokine; EEG; Sleep factors

Indexed keywords

CYTOKINE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN TEMPERATURE; CONTROLLED STUDY; DARKNESS; DOSE RESPONSE; ELECTROENCEPHALOGRAM; LIGHT; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REM SLEEP; SLEEP;

EID: 18744434242     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00191-6     Document Type: Article

References (36)

1. Agnello D., Bigini P., Vill P., Mennini T., Cerami A., Brines M., Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in an animal model of experimental autoimmune encephalomyelitis. Brain Res. 952:2002;128-134.
2. Aguilera A., Bajo M.A., Diez J.J., Ruiz-Caravaca M.L., Vicenta-Cuesta M., Alvarez V., Codoceo R., Selgas R. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients. Adv. Perit. Dial. 18:2002;200-205.
3. Bazhenov M., Timofeev I., Steriade M., Sejnowski T.J. Model of thalamocortical slow-wave sleep oscillations and transitions to activated states. J. Neurosci. 22:2002;8691-8704.
4. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science. 295:2002;2282-2285.
5. Benz R.I., Pressman M.R., Hovick E.T., Peterson D.D. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO Study). Am. J. Kidney Dis. 34:1999;1089-1095.
6. Bernaudin M., Bellail A., Marti H.H., Yvon A., Vivien D., Duchatelle I., Mackenzie E.T., Petit E. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia. 30:2000;271-278.
7. Borbely A.A. From slow wave to sleep homeostasis: new perspectives. Arch. Ital. Biol. 139:2001;53-61.
8. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., Corica F., Frisina N. The pleiotropic effects of erythropoietin in the central nervous system. J. Neuropathol. Exp. Neurol. 62:2003;228-236.
9. Cahan C., Decker M.J., Arnold J.L., Goldwasser E., Strohl K.P. Erythropoietin levels with treatment of obstructive sleep apnea. J. Appl. Physiol. 79:1995;1278-1285.
10. Cahan C., Decker M.J., Arnold J.L., Washington L.H., Veldhuis J.D., Goldwasser E., Strohl K. Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J. Appl. Physiol. 72:1992;2112-2117.
11. Clarke C.J., Taylor-Fishwick D.A., Hales A., Chernajovsky Y., Sugamura K., Feldmann M., Foxwell B.M. Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells. Eur. J. Immunol. 25:1995;2961-2966.
12. Chen L., Majde J.A., Krueger J.M. Spontaneous sleep in mice with targeted disruptions of neuronal or inducible nitric oxide synthase genes. Brain Res. 973:2003;214-222.
13. Chin K., Yu X., Beleslin-Cokic B., Liu C., Shen K., Mohrenweiser H.W., Noguchi C.T. Production and processing of erythropoietin receptor transcripts in brain. Mol. Brain Res. 81:2000;29-42.
14. Datta S., Patterson E.H., Siwek D.F. Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep. Synapse. 27:1997;69-78.
15. De A., Krueger J.M., Simasko S.M. Tumoral necrosis factor-α increases cytosolic responses of calcium to AMPA and to KCl in primary cultures of rat hippocampal neurons. Brain Res. 981:2003;133-142.
16. Digicaylioglu M., Bichet H.H., Marti R.H., Wenger L.A., Rivas C., Bauer M., Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U.S.A. 92:1995;3717-3720.
17. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature. 412:2001;641-647.
18. Genc S., Kuralay F., Genc K., Akhisaroglu M., Fadiloglu S., Yorukoglu K., Fadiloglu M., Gure A. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci. Lett. 298:2001;139-141.
19. Imada K., Leonard W.J. The Jak-STAT pathway. Mol. Immunol. 37:2000;1-11.
20. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., Kato Y. Effects of erythropoietin on neuronal activity. J. Neurochem. 72:1999;2565-2572.
21. Krantz S.B. Erythropoietin. Blood. 77:1991;419-434.
22. Kubota T., Kushikata T., Fang J., Krueger J.M. Nuclear factor-κB inhibitor peptide inhibits spontaneous and interleukin-1β-induced sleep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R404-R413.
23. Kubota T., Li N., Guan Z., Brown R.A., Krueger J.M. Intrapreoptic microinjection of TNF-alpha enhances non-REM sleep in rats. Brain Res. 932:2002;37-44.
24. Leonard T.O., Lydic R. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J. Neurosci. 17:1997;774-785.
25. Macdougall I.C., Cooper A. The inflammatory responses and epoetin sensitivity. Nephrol. Dial. Transplant. 17:2002;48-52.
26. Martin H.H., Wenger R.H., Rivas L.A., Straumann U., Digicaylioglu M., Henn V., Yonekawa Y., Bauer C., Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8:1996;666-676.
27. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 76:1997;105-116.
28. Obál F. Jr., Krueger J.M. Biochemical regulation of non-rapid-eye-movement sleep. Front. Biosci. 8:2003;d520-d550.
29. Opp M.R., Obál F. Jr., Krueger J.M. Interleukin 1 alters rat sleep: temporal and dose-related effects. Am. J. Physiol. Regul. Integr. Comp. Physiol. 260:1991;R52-R58.
30. Park J., Kwon D., Cho I.C., Oh J.W., Benveniste E.N. Chloroquine induces activation of nuclear factor-kappaB and subsequent expression of pro-inflammatory cytokines by human astroglial cells. J. Neurochem. 84:2003;1266-1274.
31. Revicki D.A., Brown R.E., Feeny D.H., Henry D., Teehan B.P., Rudnick M.R., Benz R.L. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am. J. Kidney Dis. 25:1995;548-554.
32. Sakai K., Crochet S., Onoe H. Pontine structures and mechanisms involved in the generation of paradoxical (REM) sleep. Arch. Ital. Biol. 139:2001;93-107.
33. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita M., Nagao R., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4635-4640.
34. Sinor A.D., Greenberg D.A. Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci. Lett. 290:2000;213-215.
35. Wolcott D.L., Marsh J.T., La Rue A., Carr C., Nissenson A.R. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am. J. Kidney Dis. 14:1989;478-485.
36. Yamaza T., Masuda K.F., Tsukiyama Y., Nishijima K., Murakami R., Kido M.A., Koyano K., Tanaka T. NF-kappaB activation and iNOS expression in the synovial membrane of rat temporomandibular joints after induced synovitis. J. Dent. Res. 82:2003;183-188.